*001773965
*00520190107141003.0
*007ta
*008130624s2010    no#           000 0 eng
*00901490cam a2200385 c 4500
*015  $a1112250$2nbf
*019  $bl
*020  $a9788282641210$qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)991027243504702201
*035  $a(NO-LaBS)14898943(bibid)
*035  $a(NO-TrBIB)102724350
*035  $a102724350-47bibsys_network
*040  $aNO-OsNB$bnob$ekatreg
*042  $anorbibl
*044  $cno
*060 4$aQU 325
*08274$a616.079$qNO-OsNB$25/nor
*0837 $a616.994$qNO-OsNB$25/nor
*1001 $aHolen, Halvor Lauvstad$d1979-$0(NO-TrBIB)10083684$_104841400
*24510$aEph receptor tyrosine kinases and ephrin ligands :$bexpression, interaction and function in cancer and immunity$cHalvor Lauvstad Holen
*260  $aOslo$bFaculty of Medicine, University of Oslo$c2010
*300  $a1 b. (flere pag.)$bill.
*4901 $aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo$vno. 1044
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (ph.d.) - Universitetet i Oslo, 2010
*650 2$aCell Movement$_24467300
*650 2$aEphrins$xphysiology$_104841500
*650 2$aReceptors, Antigen$xantagonists & inhibitors$_104841600
*650 2$aT-Lymphocytes$xphysiology$_72732300
*7102 $aUniversitetet i Oslo$bDet medisinske fakultet$0(NO-TrBIB)90302138$4dgg$_10213300
*830 0$aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo (trykt utg.)$x1502-9921$vno. 1044$w990122483394702201$_204428700
*901  $a90
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:991027243504702202$b2021-11-14T20:48:49Z$z991027243504702202
^